We are a German biotech company with a distinctive strategy to fight cancer. Our three academic cancer projects have demonstrated clinical proof of concept and are ready for final development by pharma. Responsible Person: ORYX GmbH & Co. KG Marktplatz 1, 85598 Baldham Reg. HRA 90888 VAT ID 258096724 General Manager: ORYX Verwaltung GmbH CEO Dr. Bernard Huber Marktplatz 1, 85598 Baldham Reg. HRB 167085 +49 81 06 21 31 10 info@oryx-medicine.com
View Top Employees from ORYX Translational MedicineWebsite | https://www.oryx-medicine.com |
Revenue | $6 million |
Employees | 3 (2 on RocketReach) |
Founded | 2007 |
Address | 1 Marktplatz, Baldham, Bavaria 85598, DE |
Phone | +49 8106 213110 |
Fax | +49 8106 2131166 |
Technologies |
JavaScript,
HTML,
PHP
+2 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Business Services |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies |
Looking for a particular ORYX Translational Medicine employee's phone or email?
The ORYX Translational Medicine annual revenue was $6 million in 2024.
Bernard Huber is the Chief Executive Officer and Founder of ORYX Translational Medicine.
2 people are employed at ORYX Translational Medicine.
ORYX Translational Medicine is based in Baldham, Bavaria.
The NAICS codes for ORYX Translational Medicine are [541, 5417, 541713, 54171, 54].
The SIC codes for ORYX Translational Medicine are [87, 873].